Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Highlights from the 2003 AACR-NCI-EORTC International Conference available on the LifeSci Channel

Dec. 23, 2003

Clinical effects of PKC-412 in acute myeloid leukemia

Dec. 22, 2003

CTCE-9908 enters phase I testing

Dec. 22, 2003

Phase II trials evaluate Vitaxin for prostate cancer and psoriasis

Dec. 19, 2003

Clinical effect observed in phase I study of BCX-1777 in T-cell malignancies

Dec. 19, 2003

Eligard approved in Australia

Dec. 19, 2003

AEterna focuses Neovastat program on NSCLC

Dec. 19, 2003

Pixantrone shows antitumor efficacy in relapsed/refractory NHL

Dec. 19, 2003

Clinical benefits of gene therapy with Ad-CD154 for CLL

Dec. 19, 2003

Novel HDAC inhibitors idenified at AstraZeneca

Dec. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...